Abiraterone Acetate
Abiraterone Acetate is a steroidal inhibitor of 17α-hydroxylase/C17,20-lyase (CYP17A1), blocking androgen synthesis. It is a key therapeutic agent for metastatic castration-resistant prostate cancer. Its efficacy has been validated in both in vitro enzymatic assays and in vivo clinical studies.
Product Specifications
CAS Number
154229-18-2
Product Name Alternative
CB 7630, CB7630, CB-7630, Cytochrome P450, CYPs, CYP17, Abiraterone, Abiraterone Acetate, Inhibitor, inhibit, Zytiga
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.51% (May vary between batches)
Solubility
DMSO:9.61 mg/mL (24.54 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.55 mM)
Smiles
C[C@@]12[C@] ([C@]3 ([C@] (CC1) ([C@]4 (C) C (=CC3) C[C@@H] (OC (C) =O) CC4) [H]) [H]) (CC=C2C=5C=CC=NC5) [H]
Molecular Formula
C26H33NO2
Molecular Weight
391.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
3- (4-Chlorophenyl) -1,2,4-oxadiazol-5 (2H) -one
RPS2P48 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)